Maruti and Cipla trade below long-term P/E averages. Both show solid fundamentals, but growth has slowed. Execution on new ...

Q3 2025 Earnings Call Transcript May 1, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $2.35, expectations were $2.17. Operator: Hello, and welcome to the Third Quarter Fiscal ...

Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

Most appealing to long-term investors is that Pfizer stock is trading near its decade-long low in terms of price to forward earnings at 7.7X and well below the high of 20.1X during this period. PFE ...

Fibmold upcycles plant fibers from ag waste into molded fiber packaging to help partners reduce their reliance on single use ...

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Kiniksa Pharmaceuticals (KNSA) delivered earnings and revenue surprises of 450% and 7.35%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

We do not see JD Health to be in any financial distress. The balance sheet has CNY 200 million of debt compared with CNY 40 billion of cash and equivalents and almost no debt as of Dec. 31, 2024. The ...

NEW DELHI: Indian pharmaceutical companies are ramping up efforts to expand their footprint in the lucrative US oncology generics market, which is currently ... the report said. Industry experts say ...